Even as Johnson & Johnson’s (New Brunswick, New Jersey) Cordis (Miami Lakes, Florida) unit was rolling out results of a three-year trial of its Cypher drug-eluting stent (DES) during the American College of Cardiology meeting, another study was being reported comparing Cypher with another DES being used in Europe.